SI2358686T1 - Aril metil benzokuinazolinon M1 receptor pozitivnih alosteričnih modulatorjev - Google Patents
Aril metil benzokuinazolinon M1 receptor pozitivnih alosteričnih modulatorjevInfo
- Publication number
- SI2358686T1 SI2358686T1 SI200930460T SI200930460T SI2358686T1 SI 2358686 T1 SI2358686 T1 SI 2358686T1 SI 200930460 T SI200930460 T SI 200930460T SI 200930460 T SI200930460 T SI 200930460T SI 2358686 T1 SI2358686 T1 SI 2358686T1
- Authority
- SI
- Slovenia
- Prior art keywords
- positive allosteric
- receptor positive
- allosteric modulators
- aryl methyl
- methyl benzoquinazolinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/19—Acids containing three or more carbon atoms
- C07C53/21—Acids containing three or more carbon atoms containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19974008P | 2008-11-20 | 2008-11-20 | |
EP09761104A EP2358686B1 (en) | 2008-11-20 | 2009-11-19 | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators |
PCT/US2009/065060 WO2010059773A1 (en) | 2008-11-20 | 2009-11-19 | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2358686T1 true SI2358686T1 (sl) | 2013-05-31 |
Family
ID=41565956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200930460T SI2358686T1 (sl) | 2008-11-20 | 2009-11-19 | Aril metil benzokuinazolinon M1 receptor pozitivnih alosteričnih modulatorjev |
Country Status (37)
Country | Link |
---|---|
US (4) | US8557832B2 (sl) |
EP (1) | EP2358686B1 (sl) |
JP (1) | JP5102397B2 (sl) |
KR (1) | KR101305590B1 (sl) |
CN (1) | CN102292323B (sl) |
BR (1) | BRPI0921924A2 (sl) |
CA (1) | CA2743562C (sl) |
CO (1) | CO6361928A2 (sl) |
CR (1) | CR20110268A (sl) |
CY (1) | CY1113665T1 (sl) |
DK (1) | DK2358686T3 (sl) |
DO (1) | DOP2011000135A (sl) |
EA (1) | EA019098B1 (sl) |
EC (1) | ECSP11011066A (sl) |
ES (1) | ES2393694T3 (sl) |
GE (1) | GEP20156348B (sl) |
GT (1) | GT201100127A (sl) |
HK (1) | HK1154587A1 (sl) |
HN (1) | HN2011001358A (sl) |
HR (1) | HRP20120992T1 (sl) |
IL (1) | IL212573A (sl) |
MA (1) | MA32898B1 (sl) |
MX (1) | MX2011005284A (sl) |
MY (1) | MY162502A (sl) |
NI (1) | NI201100100A (sl) |
NZ (1) | NZ592961A (sl) |
PE (1) | PE20120031A1 (sl) |
PL (1) | PL2358686T3 (sl) |
PT (1) | PT2358686E (sl) |
RS (1) | RS52528B (sl) |
SG (1) | SG171769A1 (sl) |
SI (1) | SI2358686T1 (sl) |
SV (1) | SV2011003912A (sl) |
TN (1) | TN2011000209A1 (sl) |
UA (1) | UA100459C2 (sl) |
WO (1) | WO2010059773A1 (sl) |
ZA (1) | ZA201103612B (sl) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012003464B8 (pt) * | 2009-08-31 | 2021-05-25 | Merck Sharp & Dohme | compostos de piranil aril metil benzoquinaozlinona, uso dos mesmos, e, composição farmacêutica |
EP2490692B1 (en) | 2009-10-21 | 2016-11-16 | Merck Sharp & Dohme Corp. | Quinolinone-pyrazolone m1 receptor positive allosteric modulators |
EP2512245B1 (en) * | 2009-12-14 | 2014-07-23 | Merck Sharp & Dohme Corp. | Pyridoquinazolinone m1 receptor positive allosteric modulators |
US9199939B2 (en) | 2009-12-17 | 2015-12-01 | Merck Sharp & Dohme Corp. | Quinoline amide M1 receptor positive allosteric modulators |
US8383638B2 (en) * | 2009-12-21 | 2013-02-26 | Merck Sharp & Dohme | Aminobenzoquinazolinone M1 receptor positive allosteric modulators |
WO2011159553A1 (en) * | 2010-06-15 | 2011-12-22 | Merck Sharp & Dohme Corp. | Heterocyclic fused phenanthrolinone m1 receptor positive allosteric modulators |
EP2588104B1 (en) | 2010-07-01 | 2014-12-10 | Merck Sharp & Dohme Corp. | Isoindolone m1 receptor positive allosteric modulators |
US8664234B2 (en) * | 2010-10-04 | 2014-03-04 | Merck Sharp & Dohme Corp. | Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators |
WO2012158473A1 (en) | 2011-05-17 | 2012-11-22 | Merck Sharp & Dohme Corp. | N-methyl tetrahydroquinoline m1 receptor positive allosteric modulators |
AR088786A1 (es) | 2011-08-12 | 2014-07-10 | Basf Se | Compuestos de antranilamida y sus usos como plaguicidas |
EP2742022A1 (en) | 2011-08-12 | 2014-06-18 | Basf Se | Anthranilamide compounds and their use as pesticides |
WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
IN2012DE00083A (sl) * | 2012-01-10 | 2015-05-01 | Council Scient Ind Res | |
US9403802B2 (en) | 2012-03-02 | 2016-08-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use therefor |
US9777005B2 (en) | 2012-11-19 | 2017-10-03 | Takeda Pharmaceutical Company Limited | Bicyclic heterocyclic compound containing a substituted pyrrole ring |
GB201317363D0 (en) | 2013-10-01 | 2013-11-13 | Eisai Ltd | Novel compounds |
DE112015001835T5 (de) | 2014-04-17 | 2016-12-29 | Sumitomo Chemical Company, Limited | Verfahren zur Herstellung einer Nitroverbindung |
WO2016144727A1 (en) * | 2015-03-06 | 2016-09-15 | Chase Pharmaceuticals Corporation | Peripheral-anticholinergic muscarinic agonist combination |
EP3313836B1 (en) * | 2015-06-26 | 2020-11-11 | Takeda Pharmaceutical Company Limited | 2,3-dihydro-4h-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic m1 receptor |
CA2996717A1 (en) | 2015-09-11 | 2017-03-16 | Chase Pharmaceuticals Corporation | Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system |
WO2017058691A1 (en) * | 2015-09-30 | 2017-04-06 | Merck Sharp & Dohme Corp. | Process for making m1 receptor positive allosteric modulators |
EP3356333A4 (en) * | 2015-09-30 | 2019-03-27 | Merck Sharp & Dohme Corp. | CRYSTAL FORMS OF AN M1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR |
US10548899B2 (en) * | 2015-10-20 | 2020-02-04 | Takeda Pharmaceutical Company Limited | Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity |
AU2017251537B2 (en) | 2016-04-15 | 2020-10-08 | Abbvie Inc. | Bromodomain inhibitors |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
UA125628C2 (uk) | 2016-10-14 | 2022-05-04 | Пі Індастріз Лтд | Похідні 4-заміщеного феніламіну і їх використання для захисту культур від небажаних фітопатогенних мікроорганізмів |
EP3535253A1 (en) | 2016-11-01 | 2019-09-11 | H. Hoffnabb-La Roche Ag | 1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of cns related diseases |
WO2018212312A1 (ja) | 2017-05-19 | 2018-11-22 | 武田薬品工業株式会社 | スクリーニング方法 |
KR20210068025A (ko) | 2018-09-28 | 2021-06-08 | 다케다 야쿠힌 고교 가부시키가이샤 | 헤테로시클릭 화합물 |
EP4308664A1 (de) | 2021-03-18 | 2024-01-24 | Merck Patent GmbH | Heteroaromatische verbindungen für organische elektrolumineszenzvorrichtungen |
WO2023114224A1 (en) | 2021-12-13 | 2023-06-22 | Sage Therapeutics, Inc. | Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2180798T3 (es) * | 1995-10-02 | 2003-02-16 | Hoffmann La Roche | Derivados de pirimidina como antagonistas del receptor de 5ht2c. |
JP2001507349A (ja) * | 1996-12-23 | 2001-06-05 | セルテック セラピューティックス リミテッド | 縮合多環式2−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用 |
JP4484368B2 (ja) * | 1998-10-16 | 2010-06-16 | 大日本住友製薬株式会社 | キナゾリノン誘導体 |
JP2005089298A (ja) * | 2001-09-18 | 2005-04-07 | Japan Tobacco Inc | ナフタレン化合物及びその医薬用途 |
US20060233843A1 (en) | 2003-02-19 | 2006-10-19 | Conn P J | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
MX2007013606A (es) * | 2005-05-04 | 2007-12-10 | Hoffmann La Roche | (3,4-dihidro-quinazolin2-il)-(2-ariloxi-etil)-aminas que tienen una actividad en el receptor 5-ht. |
CA2655787A1 (en) * | 2006-06-28 | 2008-01-03 | Merck And Co., Inc. | Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
US8664234B2 (en) * | 2010-10-04 | 2014-03-04 | Merck Sharp & Dohme Corp. | Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators |
-
2009
- 2009-11-19 CN CN200980155011.4A patent/CN102292323B/zh active Active
- 2009-11-19 MX MX2011005284A patent/MX2011005284A/es active IP Right Grant
- 2009-11-19 MY MYPI2011002215A patent/MY162502A/en unknown
- 2009-11-19 EP EP09761104A patent/EP2358686B1/en active Active
- 2009-11-19 ES ES09761104T patent/ES2393694T3/es active Active
- 2009-11-19 RS RS20120522A patent/RS52528B/en unknown
- 2009-11-19 GE GEAP200912265A patent/GEP20156348B/en unknown
- 2009-11-19 PL PL09761104T patent/PL2358686T3/pl unknown
- 2009-11-19 WO PCT/US2009/065060 patent/WO2010059773A1/en active Application Filing
- 2009-11-19 DK DK09761104.0T patent/DK2358686T3/da active
- 2009-11-19 BR BRPI0921924A patent/BRPI0921924A2/pt active Search and Examination
- 2009-11-19 JP JP2011537601A patent/JP5102397B2/ja active Active
- 2009-11-19 NZ NZ592961A patent/NZ592961A/xx not_active IP Right Cessation
- 2009-11-19 UA UAA201107595A patent/UA100459C2/ru unknown
- 2009-11-19 PT PT97611040T patent/PT2358686E/pt unknown
- 2009-11-19 US US13/129,593 patent/US8557832B2/en active Active
- 2009-11-19 EA EA201170705A patent/EA019098B1/ru not_active IP Right Cessation
- 2009-11-19 CA CA2743562A patent/CA2743562C/en active Active
- 2009-11-19 SG SG2011036472A patent/SG171769A1/en unknown
- 2009-11-19 KR KR1020117011415A patent/KR101305590B1/ko active IP Right Grant
- 2009-11-19 PE PE2011001058A patent/PE20120031A1/es not_active Application Discontinuation
- 2009-11-19 SI SI200930460T patent/SI2358686T1/sl unknown
-
2011
- 2011-04-28 IL IL212573A patent/IL212573A/en not_active IP Right Cessation
- 2011-04-29 TN TN2011000209A patent/TN2011000209A1/fr unknown
- 2011-05-12 DO DO2011000135A patent/DOP2011000135A/es unknown
- 2011-05-17 GT GT201100127A patent/GT201100127A/es unknown
- 2011-05-17 NI NI201100100A patent/NI201100100A/es unknown
- 2011-05-17 ZA ZA2011/03612A patent/ZA201103612B/en unknown
- 2011-05-19 HN HN2011001358A patent/HN2011001358A/es unknown
- 2011-05-20 EC EC2011011066A patent/ECSP11011066A/es unknown
- 2011-05-20 SV SV2011003912A patent/SV2011003912A/es unknown
- 2011-05-20 CR CR20110268A patent/CR20110268A/es unknown
- 2011-05-24 CO CO11063884A patent/CO6361928A2/es active IP Right Grant
- 2011-06-13 MA MA33939A patent/MA32898B1/fr unknown
- 2011-08-25 HK HK11108976.8A patent/HK1154587A1/xx not_active IP Right Cessation
-
2012
- 2012-12-03 HR HRP20120992AT patent/HRP20120992T1/hr unknown
- 2012-12-17 CY CY20121101227T patent/CY1113665T1/el unknown
-
2013
- 2013-08-29 US US14/013,184 patent/US8883810B2/en active Active
-
2014
- 2014-10-08 US US14/509,580 patent/US20150031713A1/en not_active Abandoned
-
2015
- 2015-08-17 US US14/828,216 patent/US9708273B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201103612B (en) | Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators | |
EP2490692A4 (en) | COMPOUNDS OF QUINOLÉINONE-PYRAZOLONE POSITIVE ALLOSTERIC MODULATORS OF THE M1 RECEPTOR | |
HK1208225A1 (en) | Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators m1 | |
EP2312949A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF M1 N-HETEROCYCLIC RECEPTOR | |
EP2244577A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF M1 RECEIVER OF QUINOLIZIDINONE TYPE | |
EP2588104A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF ISOINDOLONE M1 RECEIVER | |
EP2512245A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF PYRIDOQUINAZOLINONE M1 RECEPTORS | |
HK1170122A1 (zh) | 喹啉酰胺 受體陽性的别構調節劑 | |
EP2515656A4 (en) | POSITIVE ALLOSTERIC AMINOBENZOCHINAZOLINONE M1 RECEPTOR MODULATORS | |
EP2252151A4 (en) | POSITIVE ALLOSTERIC CHINOLIZIDINONE M1 RECEPTOR MODULATORS | |
EP2501231A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE QUINOLIZIDINONE-CARBOXAMIDE TYPE M1 RECEPTOR | |
EP2624697A4 (en) | POSITIVE ALLOSTERIC DIHYDROBENZOCHINAZOLINONE M1 RECEPTOR MODULATORS | |
BRPI0923305A2 (pt) | moduladores de receptores toll-like | |
EP2344446A4 (en) | S1P RECEPTOR MODULATORS | |
DK2297100T3 (da) | Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer | |
EP2421366A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF A HETEROCYCLIC FUSED CINNOLINE M1 RECEPTOR | |
EP2582241A4 (en) | HETEROCYCLIC FUSIONED PHENANTHROLINONE COMPOUNDS USEFUL AS POSITIVE ALLOSERIC MODULATORS OF THE M1 RECEPTOR | |
GB0701992D0 (en) | Grehlin Receptor Modulators | |
EP2563126A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF M1 RECEPTOR DERIVED FROM HETEROCYCLIC QUINOLIZINE | |
GB201004739D0 (en) | Receptor modulators | |
EP2355659A4 (en) | M1 RECEPTOR MODULATORS CONCEALED HETEROCYCLIC POSITIVE ALLOSTERIC | |
EP2709451A4 (en) | POSITIVE ALLOSTERIC N-NETWORKED LACTAM M1 RECEPTOR MODULATORS | |
EP2709621A4 (en) | POSITIVE ALLOSERIC MODULATORS OF M1 RECEPTOR TO QUINOLINE-AMIDE N-BINDING | |
EP2340247A4 (en) | POSITIVE ALLOSTERIC MODULATORS OF THE CHINOLIZIDINONE M1 RECEPTOR | |
EP2252299A4 (en) | CONDENSED PYRIDONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS |